Featured products of torrent: cabosoft inj, calflash, capehope, cardiwell, cardiwell plus, centron, 1-up, chepatron, chymoral-br, cipride, clobator, coloni. Torrent Pharmaceuticals Ltd. Brand List that includes tablets, capsules, syrups, etc. Brands listed with corresponding Generic name and price details.

Ahmedabad-headquartered drug major Torrent Pharma has managed to turn around its business in Brazil, where it is the largest Indian generics player, with revenue growing by 25 per cent in April-December to Rs 484 crore. During the third quarter, the company's Brazil business posted revenue growth of 35 per cent, year on year, to Rs 159 crore. In 2015-16, Torrent’s revenue in Brazil declined 17 per cent to Rs 506 crore.

A company spokesperson said the devaluation of the Brazilian real had overshadowed market growth. In 2015-16, revenue declined 17 per cent in dollar terms but grew. • Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the offer. By subscribing to this product you acknowledge and accept that our Partners may choose to contact you with offers of their products and services.

• This is an optional offer - Not comfortable with sharing personal data - please opt for the full price offer which requires you to share minimal information NOTE. • This product is a monthly auto renewal product. • If you have been a past Free/Registered User of The Wall Street Journal online - You will not be eligible for the seamless account creation on The Wall Street Journal online facility. Kindly your non-confidential password on The Wall Street Journal online to enable us activate your access from the backend. • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds. • To cancel, communicate from your registered email id and send the mail with the request to.

13 cl, 16 dwg Description Translated from Russian. SUBSTANCE: start of space vertical takeoff vehicle provided with liquid-propellant rocket engine and servicing plane and their joint flight are performed simultaneously; servicing plane and vertical takeoff space vehicle are connected by means of flexible propellant-transfer device before takeoff and in course of joint and parallel flight, propellant is transferred from servicing plane to space vehicle before takeoff. 4 5 predlozhenij s paralleljnoj ili cepnoj svyazjyu lyrics. Transfer of propellant to engine plant of space vehicle is started immediately after takeoff. FIELD: rocketry and space engineering; space systems for delivery of payload to far-out space and to earth orbit. EFFECT: enhanced reliability.

Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

• Saving calculated at the current WSJ price - US $ 1 for the first 3 months and US $ 28.99 thereafter Conversion scale 1 US$ = 65.04 INR • If you have been a past Free/Registered User of The Wall Street Journal online - You will not be eligible for the seamless account creation on The Wall Street Journal online facility. Kindly your non-confidential password on The Wall Street Journal online to enable us activate your access from the backend. • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds. • To cancel, communicate from your registered email id and send the mail with the request to. Include your contact number for easy reference.

Requests mailed to any other ID will not be acknowledged or actioned upon.

Notes from the AGM: I attended the AGM of Torrent Pharma in Ahmedabad & also happened to meet there. This was the first time I attended Torrent AGM. I haven’t dwelled much deeply in the company products., and I admit that I have very little understanding of the pharma play. Ankit Gupta is far more specialised into research of pharma companies & knows even the intricate details in this sector.

I would like to add my observations & notes from the AGM: On delay in launching gCrestor: The company said that it couldnt complete the product filing on time & FDA approvals for the generic versions had already been granted to 6 other players by the time (: please correct me, if I am wrong here ) On acquisition of Glochem: As mentioned by Ankit, Glochem was acquired as it was an API vendor for the company & it was available for acquisition. The company says that this acquisition would strengthen the backward integration & would reduce dependency for API on a third party. On Oncology ANDA filed: The company replied that it hasn’t yet filed any ANDA in this segment so far. On ANDA approvals received in this financial year: The company replied that it has not received any approvals yet in FY-17 On the rationale behind recent acquisitions: The company stated the following reasons for the respective acquisitions: a) Elder Pharma: Stronghold in Women Healthcare & Vitamin segment. B) Zyg Pharma: For its USFDA approved derma products c) Glochem: For its API manufacturing facility One gentleman at the AGM, Mr.